El-Tanani, M., Satyam, S. M., Rabbani, S. A., El-Tanani, Y., Sutherland, M., Muhana, F. (2025). Disruption of epidermal growth factor receptor signaling and cytoskeletal dynamics by mebendazole and gefitinib synergistically impairs paracrine cytokine signaling in non-small cell lung cancer and triple-negative breast cancer Cell lines. PLoS ONE. https://doi.org/10.1371/journal.pone.0338027